Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Emerging evidence and treatment paradigm of non-small cell lung cancer
Liu, Si-Yang Maggie, Zheng, Mei-Mei, Pan, Yi, Liu, Si-Yang, Li, Yangqiu, Wu, Yi-Long
Published in Journal of hematology and oncology (17.04.2023)
Published in Journal of hematology and oncology (17.04.2023)
Get full text
Journal Article
Genomic and immune characteristics of HER2‐mutated non‐small‐cell lung cancer and response to immune checkpoint inhibitor‐based therapy
Tu, Hai‐Yan, Yin, Kai, Zhao, Xiaotian, Ke, E‐E, Wu, Si‐Pei, Li, Yang‐Si, Zheng, Mei‐Mei, Liu, Si‐Yang Maggie, Xu, Chong‐Rui, Sun, Yue‐Li, Lin, Jia‐Xin, Bai, Xiao‐Yan, Zhang, Yi‐Chen, Zhou, Qing, Yang, Jin‐Ji, Zhong, Wen‐Zhao, Wang, Bing‐Chao, Zhang, Xu‐Chao, Zhu, Dongqin, Yang, Lingling, Ou, Qiuxiang, Wu, Yi‐Long
Published in Molecular oncology (01.08.2023)
Published in Molecular oncology (01.08.2023)
Get full text
Journal Article
Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
Dong, Song, Yan, Bingfa, Liu, Si-Yang, Gao, Xuan, Hong, Hui-Zhao, Li, Hong-Ji, Gao, Wei, Yan, Hong-Hong, Maggie Liu, Si-Yang, Tu, Hai-Yan, Pan, Yi, Zhou, Qing, Yang, Xue-Ning, Xia, Xue-Feng, Yi, Xin, Zhong, Wen-Zhao, Wu, Yi-Long, Zhang, Jia-Tao
Published in JTO clinical and research reports (01.01.2025)
Published in JTO clinical and research reports (01.01.2025)
Get full text
Journal Article
Specific TCR profiles predict clinical outcome of adjuvant EGFR-TKIs for resected EGFR-mutant non-small cell lung cancer
Liu, Si-Yang Maggie, Chen, Cunte, Zhang, Yi-Kai, Zhong, Wen-Zhao, Wu, Yi-Long, Liu, Si-Yang, Li, Yangqiu
Published in Biomarker research (07.03.2023)
Published in Biomarker research (07.03.2023)
Get full text
Journal Article
Co-enrichment of CD8-positive T cells and macrophages is associated with clinical benefit of tislelizumab in solid tumors
Ye, Dingwei, Desai, Jayesh, Shi, Jingwen, Liu, Si-Yang Maggie, Shen, Wei, Liu, Tengfei, Shi, Yang, Wang, Dan, Liang, Liang, Yang, Silu, Ma, Xiaopeng, Jin, Wei, Zhang, Pei, Huang, Ruiqi, Shen, Zhirong, Zhang, Yun, Wu, Yi-Long
Published in Biomarker research (07.03.2023)
Published in Biomarker research (07.03.2023)
Get full text
Journal Article
Predictive value of intra‐tumoural TCRβ rearrangements in precisely selecting adjuvant therapy for EGFR‐mutant non‐small‐cell lung cancer
Chen, Cunte, Liu, Si‐Yang Maggie, Wu, Yi‐Long, Liu, Si‐Yang, Li, Yangqiu
Published in Clinical and translational discovery (01.06.2022)
Published in Clinical and translational discovery (01.06.2022)
Get full text
Journal Article
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Maggie Liu, Si-Yang, Huang, Jie, Deng, Jia-Yi, Xu, Chong-Rui, Yan, Hong-Hong, Yang, Ming-Yi, Li, Yang-Si, Ke, E-E, Zheng, Ming-Ying, Wang, Zhen, Lin, Jia-Xin, Gan, Bin, Zhang, Xu-Chao, Chen, Hua-Jun, Wang, Bin-Chao, Tu, Hai-Yan, Yang, Jin-Ji, Zhong, Wen-Zhao, Li, Yangqiu, Zhou, Qing, Wu, Yi-Long
Published in Science bulletin (Beijing) (26.02.2024)
Published in Science bulletin (Beijing) (26.02.2024)
Get full text
Journal Article
A risk score combining co-expression modules related to myeloid cells and alternative splicing associates with response to PD-1/PD-L1 blockade in non-small cell lung cancer
Han, Yichao, Liu, Si-Yang Maggie, Jin, Runsen, Meng, Wangyang, Wu, Yi-Long, Li, Hecheng
Published in Frontiers in immunology (10.07.2023)
Published in Frontiers in immunology (10.07.2023)
Get full text
Journal Article
Targeted Therapy in Early Stage Non-small Cell Lung Cancer
Liu, Si-Yang, Liu, Si-Yang Maggie, Zhong, Wen-Zhao, Wu, Yi-Long
Published in Current treatment options in oncology (01.09.2022)
Published in Current treatment options in oncology (01.09.2022)
Get full text
Journal Article
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Li, Yang-Si, Lai, Wen-Pu, Yin, Kai, Zheng, Mei-Mei, Tu, Hai-Yan, Guo, Wei-Bang, Li, Liang, Lin, Shou-Heng, Wang, Zhen, Zeng, Lu, Jiang, Ben-Yuan, Chen, Zhi-Hong, Zhou, Qing, Zhang, Xu-Chao, Yang, Jin-Ji, Zhong, Wen-Zhao, Yang, Xue-Ning, Wang, Bin-Chao, Pan, Yi, Chen, Hua-Jun, Xiao, Fa-Man, Sun, Hao, Sun, Yue-Li, Bai, Xiao-Yan, Ke, E.-E., Lin, Jia-Xin, Liu, Si-Yang Maggie, Li, Yangqiu, Luo, Oscar Junhong, Wu, Yi-Long
Published in Cell reports (Cambridge) (27.08.2024)
Published in Cell reports (Cambridge) (27.08.2024)
Get full text
Journal Article
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
Zhang, Jia-Tao, Dong, Song, Gu, Wei-Quan, Zhao, Ning, Liang, Yi, Tang, Wen-Fang, Liu, Shuo-Yan, Wang, Feng, Wang, Guang-Suo, Peng, Bin, Wu, Nan, Yan, Shi, Geng, Guo-Jun, Xie, Ze-Feng, Yang, Yan-Long, Zhang, Jian-Hua, Zhang, Tao, Yang, Nuo, Jiao, Wen-Jie, Xiong, Yuan-Yuan, Cai, Miao, Li, Fang, Chen, Rong-Rong, Yan, Hong-Hong, Maggie Liu, Si-Yang, Yi, Xin, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Published in Clinical lung cancer (01.01.2024)
Published in Clinical lung cancer (01.01.2024)
Get full text
Journal Article
Consensus on the lung cancer management after third-generation EGFR-TKI resistance
Zhou, Qing, Zhao, Hongyun, Lu, Shun, Cheng, Ying, Liu, Ying, Zhao, Mingfang, Yu, Zhuang, Hu, Chengping, Zhang, Li, Yang, Fan, Zhao, Jun, Guo, Renhua, Ma, Rui, Du, Yingying, Dong, Xiaorong, Cui, Jiuwei, Tan, Daniel S.W., Ahn, Myung-Ju, Tsuboi, Masahiro, Maggie Liu, Si-Yang, Mok, Tony S., Wu, Yi-Long
Published in The Lancet regional health. Western Pacific (01.12.2024)
Published in The Lancet regional health. Western Pacific (01.12.2024)
Get full text
Journal Article
Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial
Chen, Cunte, Liu, Si-Yang Maggie, Chen, Yedan, Ou, Qiuxiang, Bao, Hua, Xu, Ling, Zhang, Yikai, Zhong, Wenzhao, Zhou, Qing, Yang, Xue-Ning, Shao, Yang, Wu, Yi-Long, Liu, Si-Yang, Li, Yangqiu
Published in JCI insight (11.01.2022)
Published in JCI insight (11.01.2022)
Get full text
Journal Article
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study
Liu, Si-Yang, Dong, Song, Yang, Xue-Ning, Liao, Ri-Qiang, Jiang, Ben-Yuan, Wang, Qun, Ben, Xiao-Song, Qiao, Gui-Bin, Lin, Jun-Tao, Yan, Hong-Hong, Yan, Li-Xu, Nie, Qiang, Tu, Hai-Yan, Wang, Bin-Chao, Yang, Jin-Ji, Zhou, Qing, Li, Hong-Rui, Liu, Ke, Wu, Wendy, Liu, Si-Yang Maggie, Zhong, Wen-Zhao, Wu, Yi-Long
Published in Signal transduction and targeted therapy (06.12.2023)
Published in Signal transduction and targeted therapy (06.12.2023)
Get full text
Journal Article
Drug development and evidence for lung cancer targeted therapy in Eastern Asia
Maggie Liu, Si-Yang, Jin, Zhen-Yi, Deng, Jia-Yi, Zhong, Si-Min, Ahn, Myung-Ju, Horinouchi, Hidehito, Li, Yangqiu, Wu, Yi-Long
Published in The Lancet regional health. Western Pacific (01.08.2024)
Published in The Lancet regional health. Western Pacific (01.08.2024)
Get full text
Journal Article
Longitudinal Plasma Proteomics-Derived Biomarkers Predict Response to MET Inhibitors for MET-Dysregulated NSCLC
Jie, Guang-Ling, Peng, Lun-Xi, Zheng, Mei-Mei, Sun, Hao, Wang, Song-Rong, Liu, Si-Yang Maggie, Yin, Kai, Chen, Zhi-Hong, Tian, Hong-Xia, Yang, Jin-Ji, Zhang, Xu-Chao, Tu, Hai-Yan, Zhou, Qing, Wong, Catherine C. L., Wu, Yi-Long
Published in Cancers (01.01.2023)
Published in Cancers (01.01.2023)
Get full text
Journal Article
Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score
Liu, Si-Yang Maggie, Sun, Hao, Zhou, Jia-Ying, Zhang, Jia-Tao, Yin, Kai, Chen, Zhi-Hong, Su, Jian, Zhang, Xu-Chao, Yang, Jin-Ji, Zhou, Qing, Tu, Hai-Yan, Wu, Yi-Long
Published in Translational oncology (01.01.2022)
Published in Translational oncology (01.01.2022)
Get full text
Journal Article
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial
Maggie Liu, Si-Yang, Dong, Xiao-Rong, Wang, Zhen, Du, Yingying, Cui, Jiu-Wei, Chu, Qian, Xu, Bing-Fei, Zheng, Ming-Ying, Deng, Jia-Yi, Lu, Chang, Wei, Xue-Wu, Li, Yang-Si, Zheng, Mei-Mei, Yang, Ming-Yi, Huang, Jie, Li, Anna, Bai, Xiao-Yan, Sun, Yue-Li, Xu, Chong-Rui, Wang, Bin-Chao, Chen, Hua-Jun, Yang, Jin-Ji, Yan, Hong-Hong, Zhong, Wen-Zhao, Zhou, Qing, Wu, Yi-Long
Published in EClinicalMedicine (01.10.2023)
Published in EClinicalMedicine (01.10.2023)
Get full text
Journal Article
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer
Zhang, Jia-Tao, Liu, Si-Yang, Gao, Wei, Liu, Si-Yang Maggie, Yan, Hong-Hong, Ji, Liyan, Chen, Yu, Gong, Yuhua, Lu, Hong-Lian, Lin, Jun-Tao, Yin, Kai, Jiang, Ben-Yuan, Nie, Qiang, Liao, Ri-Qiang, Dong, Song, Guan, Yanfang, Dai, Pingping, Zhang, Xu-Chao, Yang, Jin-Ji, Tu, Hai-Yan, Xia, Xuefeng, Yi, Xin, Zhou, Qing, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Published in Cancer discovery (06.07.2022)
Published in Cancer discovery (06.07.2022)
Get full text
Journal Article